• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    24.35 Down 0.70(2.79%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:25.05
    Open:25.06
    Bid:22.50 x 1000
    Ask:31.79 x 600
    1y Target Est:38.40
    Beta:2.33
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:24.06 - 25.66
    52wk Range:11.93 - 32.82
    Volume:893,128
    Avg Vol (3m):1,618,740
    Market Cap:2.40B
    P/E (ttm):N/A
    EPS (ttm):-1.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLDX

    Comparison

    Symbol% ChgMkt Cap
    CLDXDown 2.79%2.40B
    DNDN 0.00%0.00
    LLYUp 1.52%91.22B
    RHHBYUp 0.09%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):674.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.41
    Quarterly EPS Est (Jun-15) :-0.34
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback